ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

Arzerra Promising For Heavily Pre-Treated CLL Patients

December 26, 2008

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

ASCO Sees Efforts Pay Off In Health Care Reform: Clinical Trials

October 1, 1993

NCI Bypass Budget Seeks $3.64 Billion

January 20, 1995

FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination

January 10, 2014